The global Silymarin market was valued at US$ 87 million in 2019 and is expected to reach US$ 105.4 million by the end of 2026, growing at a CAGR of 3.2% during 2021-2026.
Silymarin is a flavonolignans extracted from the milk thistle Silybum marianum (L.) gaernt. Silymarin has been shown to possess various pharmacological properties like hepatoprotective, antioxidant, antiinflammatory, anticancer, and cardioprotective activities.
The top players cover LIVERD PHARMA, TY Pharmaceutical, KEB Biotech, etc. The Top 3 players in Global Silymarin market revenue was 50.46% in 2019, while the share of top 5 players was 61.99%. TY Pharmaceutical is the leading supplier of Silymarin, the production of which reached 438 MT in 2019, accounting for about 18.81% of the Global market. Market concentration is high. Except policy affect, downstream demand is the key influence factor to the market.
Global Silymarin Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Silymarin Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Liverd Pharma, Huacheng Pharmaceutical, TY Pharmaceutical, Teva API, KEB Biotech, Shengbo Silymarin, Panjin Fengrui, Jiaherb and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Find more details at: https://www.themarketreports.com/report/global-silymarin-market-research-report
Segment by Type
- Silymarin Extracted by Acetone
- Silymarin Extracted by Ethyl Acetate
- Silymarin Extracted by Ethanol
- Water Soluble Silymarin
Segment by Application
- Pharma and Healthcare
- Food Additives
- Cosmetic and Skin Care
Table of Content:
1 Silymarin Market Overview
2 Silymarin Market Competition by Manufacturers
3 Silymarin Retrospective Market Scenario by Region
4 Global Silymarin Historic Market Analysis by Type
5 Global Silymarin Historic Market Analysis by Application
6 Key Companies Profiled
7 Silymarin Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Silymarin Market Dynamics
10 Global Silymarin Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta
Peter Barzilai is a high school pitcher and college rower turned longtime World News journalist. Peter has also written for Buzz Feed and Huffington Post and many other major publications, Peter Loves everything about sports and loves to write on trending topics and he is DailyFactsNTrends member since 2017.